However, a recent study did not support this finding but rather attributed the increased risk of insulin resistance to the concomitant presence of metabolic dysfunctionassociated steatotic liver disease (MASLD) (81)
By Indication, Type 2 Diabetes mellitus leads the market, due to high prevalence, strong glycemic control, and clinical benefits Type 2 Diabetes Mellitus (T2DM) dominates the GLP-1 receptor agonist market, with a 61.7% share in 2025 , driven by its high global prevalence
By combining the Molly autoinjector with Alba and Nexa PFSs, the partners provide performance data across critical attributes cap removal force, activation force, injection time, needle extension and dose accuracy
But until we have that information, we shouldn't experiment with patients outside of a research setting." Next Steps and Useful Resources Want to discuss your weight loss options more
This practice serves multiple purposes
The fix is to stop using that spot, allow several weeks for it to heal, and rotate more consistently going forward